https://ift.tt/eA8V8J
https://www.ndtv.com
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis,...
from NDTV News - Topstories https://ift.tt/3CzxYlY
via IFTTT
Post a Comment